Sound waves and immunotherapy: a new combo against breast cancer?
NCT ID NCT03237572
First seen Feb 11, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This early study tested whether using high-intensity focused ultrasound (HIFU) before or after the immunotherapy drug pembrolizumab could help the immune system better attack metastatic breast cancer. Only 13 people took part before the study was stopped early. The main goal was to see changes in immune cells inside tumors, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Virginia
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.